Agoracom Blog Home

Posts Tagged ‘HeartCheck’

CLIENT FEATURE: CardioComm Solutions $ – Connecting Your Heart To The Cloud $ $ $ $ $

Posted by AGORACOM-JC at 3:45 PM on Tuesday, March 26th, 2019

Global Leaders in Mobile  ECG Connectivity

  • 20 years of medical credibility licensing technologies to hospitals, physicians, remote patient monitoring  platforms, research groups and commercial call centers
  • Sold into > 20 countries, with the largest customer base located in the US
  • Class II medical device clearances and device agnostic for collecting, viewing, recording, analyzing and  storing of ECGs for management of patient and consumer health
  • ECG solutions for both consumer (OTC) and medical (Rx) markets
  • Owns all IP and source code
  • Market expert contributor for reports in m‐health, mobile cardiac monitoring and new advances in  consumer health and wellness monitoring

Recent Highlights

CardioComm Solutions Launches New GEM(TM) Mobile Universal ECG App Expanding ECG Reporting Services Across Global Markets Read More

  • Announced the release of a new version of the Company’s recently cleared US Food and Drug Administration (“FDA“) GEMS™ Mobile ECG app.
  • The new version is branded as the GEMS™ Universal ECG (“GEMS™ Universal“) and is capable of connecting with multiple manufacturer’s consumer and prescription ECG devices sold globally.

CardioComm Solutions Leverages the GEMS(TM) Mobile ECG App to Bring a Third FDA Cleared HeartCheck(TM) Branded ECG Device to the US Consumer Markets Read More

  • Confirms the start of an OEM co-marketing agreement for the HeartCheck™ Palm handheld ECG device, the Company’s newest GEMS™ Mobile ECG app (“GEMSTM Mobile“) enabled ECG device.
  • HeartCheck™ Palm will be the Company’s third US Food and Drug Administration (“FDA“) cleared HeartCheck™ branded handheld ECG device for over-the-counter (“OTC”) sales.


 FULL DISCLOSURE: CardioComm Solutions Inc. is an advertising client of AGORA Internet Relations Corp.